mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.1 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |